In 2020, the global insulin market reached USD 26.80 billion, and it is projected to exhibit a compound annual growth rate (CAGR) of 4.2% during the forecast period. Factors such as the increasing global burden of diabetes and obesity, rapid lifestyle changes, a growing elderly population worldwide, and advancements in insulin pens and devices are anticipated to contribute to the revenue growth of the market.
https://www.reportsanddata.com..../report-detail/insul
Like
Comment
Share
